Followers | 53 |
Posts | 3489 |
Boards Moderated | 0 |
Alias Born | 02/05/2014 |
Friday, April 29, 2016 7:53:42 PM
DNA is a publicly traded corporation.
When a publicly traded corporation, or even a private corporation, wants funding, there are only two ways to get it:
1) a corporate official goes to a financial institution and obtains a business loan.
2) the corporation exchanges some equity in corporation (ie: sells shares of corporate stock) for cash.
In order to qualify for a business loan... and it really does NOT matter what one's reputation is... either the corporation MUST have revenue or assets sufficient to meet the financial institution's qualification standards, or else the corporate official MUST personally guarantee repayment (ie: co-sign for the loan).
Sorry, but no one is going personally consign for a loan to fund a corporation that is down such as any triple zero OTC Pink. Adrian could easily get completely wiped out from a personal finance standpoint, and he would be nuts to take that big a risk on funding a comeback for DNA.
So, the natural question is why should you then help find it?
If you were putting hundreds of thousands of dollars into DNAX stock, you would have basis to ask that question with the same level of intensity as Adrian would if he personally funded the whole tbing, but I doubt that you have that much invested, or are thinking about it.
The most I think I have heard is $30-35K by one person which I think is WAY too much, but different people have different financial solutions.
Regardless of how well someone may think of Adrian, no financial institution official can just give Adrian a bank loan without the proper collateral to justify the loan unless that financial institution official wants to put their own job at risk by fudging the truth about the loan.
So, if such a person would be "willing to back him (with a loan of personal funds)," they still would want the appropriate amount of corporate stock to secure that backing.
So again I ask... because we don't know if Adrian has already acquired the necessary funding to reboot the company through dilution since February, or not... would you prefer a R/S or an increase in the A/S (and if so, how high should the A/S go?)???
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM